1. Editorial Mission
Operator Notes exists to document operational architecture that recurs across solo and small-team clinical practice. The series publishes synthesized frameworks, decision rules, and governance patterns. It does not publish novel research, regulatory guidance, or clinical advice.
The intended reader is an operator: someone who runs a small practice, carries real consequence, and would benefit from seeing how another operator has thought through a recurring problem.
2. Editorial Standards
Voice
First or third person, institutional or personal byline at the author's choice. Plain prose. No jargon without definition on first use. No hedging language that obscures rather than clarifies.
Citations
Citations are load-bearing, not decorative. Every claim that a reader might act on is cited to a primary source (statute, regulation, peer-reviewed study, agency guidance, court decision, or a prior Operator Notes issue). Secondary sources are used for context only.
Typography and Format
Every paper ships on the locked Pivotal letterhead: black field (#020203), gold gradient display (#f6d67a to #8a6a25), Trajan or Cinzel for display, Cormorant Garamond for body. Letter size, 0.7 by 0.85 inch margins. Rendered as PDF, archived in the deploy tree, served at a permanent short URL.
Prohibited Elements
- Em dashes (U+2014) and en dashes (U+2013). Use periods, colons, semicolons, commas, or plain hyphens.
- Named clients, patients, or identifiable human subjects. All case material is anonymized at minimum, and typically framed as composite.
- Clinical dosing recommendations presented as directives. Frameworks yes, prescriptions no.
- Marketing language for Pivotal Protocol products. Operator Notes is editorial, not promotional.
3. Submission Guidelines
Operator Notes accepts unsolicited submissions from practicing operators in clinical and clinical-adjacent fields. Submissions should be treated as proposals, not finished papers.
What to Send
- Proposal. One page. Working title, thesis in one paragraph, intended audience, and why an operator reader would benefit.
- Outline. Section headers with one-line descriptions.
- Author bio. One paragraph. Role, field, relevant operator experience. Include any financial or professional ties that could influence the framing.
Where to Send
Email the proposal to [email protected] with the subject line "Operator Notes Submission: [Working Title]."
Review Timeline
Proposals receive a first response within 14 days. Accepted proposals enter a draft-review-revise cycle targeting publication in 8 to 12 weeks. Rejected proposals receive a short note explaining why.
Rights
Authors retain copyright. Operator Notes retains perpetual non-exclusive license to publish, distribute, and archive. Authors may republish elsewhere after 90 days with a reference to the Operator Notes original.
4. Conflict of Interest Disclosure Standard
Every published paper includes a disclosure statement. Operators bring real commercial relationships to their work. Those relationships are not a reason for exclusion. Undisclosed relationships are.
Required Disclosures
- Financial ties. Equity, advisory fees, consulting income, speaking fees, or paid partnerships with any party whose product, service, or policy is discussed in the paper.
- Professional ties. Board seats, employment relationships, or formal affiliations with any entity whose work is discussed.
- Prior engagements. Any commercial relationship within the prior 24 months that a reasonable reader would consider relevant.
- No conflict. A declaration of none, explicitly, rather than silence.
Board Member Disclosures
Editorial Board members disclose publicly at time of appointment and update disclosures annually. Board members recuse from reviewing papers that touch their disclosed ties.
5. Editorial Board
Purpose
The Editorial Board exists to apply operator-level review to papers before publication and to anchor Operator Notes as a credible venue rather than a solo channel. Board membership is not compensated.
Seat Criteria
- Operator, not theorist. Board members are people who run something real and carry real consequence for its outcomes.
- Adjacent field. Board members work in fields adjacent to clinical peptide practice, not competitive with it. Compounding, functional medicine, regulatory law, harm reduction, clinical research, sovereignty-focused technology, veterinary therapeutics, supply-chain integrity, and related areas qualify.
- Public reputation. Board members have a public footprint a skeptical reader can verify in under a minute.
- Discipline on follow-through. Board members reliably respond to requests within 14 days.
Responsibilities
- Review one paper per quarter. Roughly 30 to 45 minutes per review.
- Return one of three verdicts: ready, revise, or reject. Short written reasoning on revise or reject.
- Disclose conflicts at appointment and annually.
- Recuse from papers touching disclosed ties.
Term and Rotation
Board seats are two-year terms, renewable. Seats may be vacated by the seat-holder at any time with a single email. Vacated seats are refilled within 60 days.
6. Corrections and Retractions
Papers are versioned. If a substantive error is discovered post-publication, a correction is issued at the same URL with a corrigendum note and a new version number. The prior version is archived, not deleted.
Retraction is reserved for fabrication, plagiarism, or disclosure failure. Retracted papers remain accessible with a prominent retraction watermark and a link to the explanation.
7. Archive and Preservation
Every issue is archived in the Pivotal Protocol deploy tree with a stable short URL and a permanent direct URL. The landing page and RSS feed index all published issues. An ISSN application is pending with the U.S. Library of Congress ISSN Center. When assigned, the ISSN appears on every paper colophon, in the RSS channel metadata, and on this page.
8. Contact
Editorial inquiries: [email protected]
Corrections and corrigenda: [email protected]
Board appointments are by invitation.